The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Uranova N.A.

Mental Health Research Centre

Vikhreva O.V.

Mental Health Research Centre

Rakhmanova V.I.

Mental Health Research Center

Specific interactions between microglia and oligodendrocytes in white matter in continuous schizophrenia

Authors:

Uranova N.A., Vikhreva O.V., Rakhmanova V.I.

More about the authors

Read: 1922 times


To cite this article:

Uranova NA, Vikhreva OV, Rakhmanova VI. Specific interactions between microglia and oligodendrocytes in white matter in continuous schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(12):128‑137. (In Russ.)
https://doi.org/10.17116/jnevro2022122121128

Recommended articles:
The role of immuno-inflammatory factors in the deve­lopment of nega­tive symptoms in schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):42-48
A role of transcription factors in pathogenic processes asso­ciated with schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):49-54
Meta­bolic syndrome and anti­psychotic therapy of schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):165-170
PANSS six-factor model. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):28-34
Clinical and immu­nological rela­tionships in patients with early schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):35-42
Clinical and psychopathological features of treatment-resistant schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):43-50

References:

  1. Takahashi N, Sakurai T, Davis KL, Buxbaum JD. Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia. Prog Neurobiol. 2011;93(1):13-24.  https://doi.org/10.1016/j.pneurobio.2010.09.004
  2. Hof PR, Haroutunian V, Friedrich VL, et al. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry. 2003;53:1075-1085. https://doi.org/10.1016/S0006-3223(03)00237-3
  3. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI. Oligodendroglial density in the prefrontal cortex area 9 in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res. 2004;67(2-3):269-275.  https://doi.org/10.1016/S0920-9964(03)00181-6
  4. Vostrikov VM, Uranova NA, Rakhmanova VI, Orlovskaia DD. Lowered oligodendroglial cell density in the prefrontal cortex in schizophrenia. Zh Nevrol Psikhiatr im. S.S. Korsakova. 2004;104(1):47-51. (In Russ.).
  5. Flynn SW, Lang DJ, Mackay AL et al. Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Mol Psychiatry. 2003;8(9):811-820.  https://doi.org/10.1038/sj.mp.4001337
  6. Maas DA, Vallès A, Martens GJM. Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia. Transl Psychiatry. 2017;7(7):e1171. https://doi.org/10.1038/tp.2017.138
  7. Mansouri FA, Koechlin E, Rosa MGP, Buckley MJ. Managing competing goals — a key role for the frontopolar cortex. Nat Rev Neurosci. 2017;18(11):645-657.  https://doi.org/10.1038/nrn.2017.111
  8. Natalya Uranova. The Neuropathology of white matter in schizophrenia. In book: The Neuropathology of schizophrenia; 2021;179-219.  https://doi.org/10.1007/978-3-030-68308-5
  9. Vikhreva OV, Rakhmanova VI, Orlovskaya DD, Uranova NA. Ultrastructural alterations of oligodendrocytes in prefrontal white matter in schizophrenia: A post-mortem morphometric study. Schizophr Res. 2016;177(1-3):28-36.  https://doi.org/10.1016/j.schres.2016.04.023
  10. Dietz AG, Goldman SA, Nedergaard M. Glial cells in schizophrenia: a unified hypothesis. Lancet Psychiatry. 2020;7(3):272-281.  https://doi.org/10.1016/S2215-0366(19)30302-5
  11. Monji A, Kato TA, Mizoguchi Y et al. Neuroinflammation in schizophrenia especially focused on the role of microglia. Prog Neuropsychopharmacol Biol Psychiatry. 2013;42:115-121.  https://doi.org/10.1016/j.pnpbp.2011.12.002
  12. Najjar S, Pearlman DM. Neuroinfammation and white matter pathology in schizophrenia: systematic review. Schizophr Res. 2015;161:102-112.  https://doi.org/10.1016/j.schres.2014.04.041
  13. Müller N. Inflammation in Schizophrenia: Pathogenetic aspects and therapeutic considerations. Schizophr Bull. 2018;44(5):973-982.  https://doi.org/10.1093/schbul/sby024
  14. Janova H, Arinrad S, Balmuth E, et al. Microglia ablation alleviates myelin-associated catatonic signs in mice. J Clin Invest. 2018;128(2):734-745.  https://doi.org/10.1172/JCI97032
  15. Hagemeyer N, Hanft K-M, Akriditou M-A, et al. Microglia contribute to normal myelinogenesis and to oligodendrocyte progenitor maintenance during adulthood. Acta Neuropathol. 2017;134(3):441-458.  https://doi.org/10.1007/s00401-017-1747-1
  16. Parkhurst CN, Yang G, Ninan I, et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell. 2013;155:1596-1609. https://doi.org/10.1016/j.cell.2013.11.030
  17. Miron VE, Boyd A, Zhao J-W, et al. M2 microglia/macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci. 2013;16:1211-1218. https://doi.org/10.1038/nn.3469
  18. Chew LJ, Fusar-Poli P, Schmitz T. Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia. Dev Neurosci. 2013;35:102-129.  https://doi.org/10.1159/000346157
  19. Taylor DL, Pirianov G, Holland S, et al. Attenuation of proliferation in oligodendrocyte precursor cells by activated microglia. J Neurosci Res. 2010;88(8):1632-1644. https://doi.org/10.1002/jnr.22335
  20. Hercher C, Chopra V, Beasley CL. Evidence for morphological alterations in prefrontal white matter glia in schizophrenia and bipolar disorder. J Psychiatry Neurosci. 2014;39(6):376-385.  https://doi.org/10.1503/jpn.130277
  21. Bernstein HG, Jauch E, Dobrowolny H, et al. Increased density of DISC1-immunoreactive oligodendroglial cells in fronto-parietal white matter of patients with paranoid schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2016;266(6):495-504.  https://doi.org/10.1007/s00406-015-0640-y
  22. Fillman SG, Cloonan N, Catts VS, et al. Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry. 2013;18(2):206-214.  https://doi.org/10.1038/mp.2012.110
  23. Gober R, Ardalan M, Shiadeh SMJ, et al. Microglia activation in postmortem brains with schizophrenia demonstrates distinct morphological changes between brain regions. Brain Pathol. 2022;32(1):e13003. https://doi.org/10.1111/bpa.13003
  24. Uranova NA, Vikhreva OV, Rakhmanova VI. Abnormal microglial reactivity in gray matter of the prefrontal cortex in schizophrenia. Asian J Psychiatr. 202;63:102752. https://doi.org/10.1016/j.ajp.2021.102752
  25. Vikhreva OV, Uranova NA. Microglial reactivity in the prefrontal cortex in different types of schizophrenia. Zh Nevrol Psikhiatr im. S.S. Korsakova. 2021;121(12):77-83. (In Russ.). https://doi.org/10.17116/jnevro202112112177
  26. Uranova NA, Vikhreva OV, Rakhmanova VI, Orlovskaya DD. Ultrastructural pathology of oligodendrocytes in the white matter in continuous paranoid paranoid schizophrenia: a role for microglia. Zh Nevrol i Psihiatr im. S.S. Korsakova. 2017;117(9):76-81. (In Russ.). https://doi.org/10.17116/jnevro20171179176-81
  27. Vikhreva OV, Rakhmanova VI, Orlovskaya DD, Uranova NA. Ultrastructural pathology of oligodendrocytes in white matter in continuous attack-like schizophrenia and a role for microglia. Zh Nevrol Psikhiatr im S.S. Korsakova. 2018;118(5):69-74. (In Russ.). https://doi.org/10.17116/jnevro20181185169
  28. Gadecka A, Bielak-Zmijewska A. Slowing Down Ageing: The Role of Nutrients and Microbiota in Modulation of the Epigenome. Nutrients. 2019;11(6):1251. https://doi.org/10.3390/nu11061251
  29. Liu JP. Molecular mechanisms of ageing and related diseases. Clin Exp Pharmacol Physiol. 2014;41(7):445-458.  https://doi.org/10.1111/1440-1681.12247
  30. Lopes KP, Snijders GJL, Humphrey J, et al. Genetic analysis of the human microglial transcriptome across brain regions, aging and disease pathologies. Nat Genet. 2022;54(1):4-17.  https://doi.org/10.1038/s41588-021-00976-y
  31. Qiu X, Xiao X, Li N, Li Y. Histone deacetylases inhibitors (HDACis) as novel therapeutic application in various clinical diseases. Prog Neuropsychopharmacol Biol Psychiatr. 2017;72:60-72.  https://doi.org/10.1016/j.pnpbp.2016.09.002
  32. Thomas EA. Histone Posttranslational Modifications in Schizophrenia. Adv Exp Med Biol. 2017;978:237-254.  https://doi.org/10.1007/978-3-319-53889-1_13
  33. Swathy B, Banerjee M. Understanding epigenetics of schizophrenia in the backdrop of its antipsychotic drug therapy. Epigenomics. 2017;9:721-736.  https://doi.org/10.2217/epi-2016-0106
  34. Chen X, Liu H, Gan J, et al. Quetiapine Modulates Histone Methylation Status in Oligodendroglia and Rescues Adolescent Behavioral Alterations of Socially Isolated Mice. Front Psychiatry. 2020;10:984.  https://doi.org/10.3389/fpsyt.2019.00984
  35. Shimamoto-Mitsuyama C, Nakaya A, Esaki K, et al. Lipid Pathology of the Corpus Callosum in Schizophrenia and the Potential Role of Abnormal Gene Regulatory Networks with Reduced Microglial Marker Expression. Cereb Cortex. 2021;31(1):448-462.  https://doi.org/10.1093/cercor/bhaa236
  36. Snijders GJLJ, van Zuiden W, Sneeboer MAM, et al. A loss of mature microglial markers without immune activation in schizophrenia. Glia. 2021;69(5):1251-1267. https://doi.org/10.1002/glia.23962
  37. Kochunov P, Glahn DC, Rowland LM, et al. Testing the hypothesis of accelerated cerebral white matter aging in schizophrenia and major depression. Biol Psychiatry. 2013;73(5):482-491.  https://doi.org/10.1016/j.biopsych.2012.10.002
  38. Kirkpatrick B, Kennedy BK. Accelerated aging in schizophrenia and related disorders: future research. Schizophr Res. 2018;196:4-8.  https://doi.org/10.1016/j.schres.2017.06.034
  39. Glezer II, Sukhorukova LI. Structural features of neuroglia in schizophrenia of the periodic and uninterruped types (histological and electron microscopic study). Zh Nevrol Psikhiatr im. S.S. Korsakova. 1966;66(10):1529-1537. (In Russ.).
  40. Sukhorukova LI. Changes in neuroglia in continuous schizophrenia. Zh Nevrol Psikhiatr im. S.S. Korsakova.1966;66(9):1408-1416. (In Russ.).
  41. Comer AL, Carrier M, Tremblay M-È, Cruz-Martín A. The inflamed brain in schizophrenia: the convergence of genetic and environmental risk factors that lead to uncontrolled neuroinflammation. Front Cell Neurosci. 2020;14:274.  https://doi.org/10.3389/fncel.2020.00274
  42. Bergink V, Gibney SM, Drexhage HA. Autoimmunity, inflammation, and psychosis: a search for peripheral markers. Biol Psychiatry. 2014;75:324-331.  https://doi.org/10.1016/j.biopsych.2013.09.037

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.